Ranbaxy and Sun get FDA OK for generic Imitrex
This article was originally published in Scrip
Executive Summary
Ranbaxy Laboratories' US subsidiary and Sun Pharma and its subsidiaries have received final approval from the US FDA to manufacture and market sumatriptan succinate tablets 25mg (base), and 50mg (base), generic versions of GlaxoSmithKline's antimigraine, Imitrex.